SAJJAD SARWAR: Open Payments
NPI 1982839957 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 48 payments from 7 companies in 2025. Trend: 2023 $83 · 2024 $466 · 2025 $967
Food & beverage: $856Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 27 | $386 |
| E.R. Squibb & Sons, L.L.C. | 13 | $317 |
| ABBVIE INC. | 3 | $150 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: COBENFY, UZEDY, VRAYLAR, AUSTEDO XR, REXULTI, Auvelity, FANAPT, Jornay PM.
Industry payments across MI — which companies pay providers there.
